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Abstract: Introduction: Ventilator-associated pneumonia (VAP) is one of the most common hospital infections and a side
effect of lengthy stay in intensive care unit (ICU). Considering the ever-changing pattern of common pathogens
in infectious diseases and the raise in prevalence of hospital infections, the present study was designed aiming
to determine the prevalence of VAP and its bacterial causes. Methods: In this cross-sectional study, the medical
profiles of all the patients under mechanical ventilation, who had no symptoms of pneumonia at the time of in-
tubation and developed new infiltration in chest radiography after 48 hours under mechanical ventilation along
with at least 2 of the symptoms including fever, hypothermia, leukocytosis, leukopenia, or purulent discharge
from the lungs, were evaluated. Demographic data, clinical and laboratory findings, and final outcome of the
patients were extracted from the patient’s clinical profile and reported using SPSS version 20 and descriptive
statistics. Results: 518 patients with the mean age of 62.3 ± 20.8 years were evaluated (50.9% female). Mean
time interval between intubation and showing symptoms was 10.89 ± 12.27 days. Purulent discharges (100%),
leukocytosis (71.9%), fever (49.1%), hypothermia (12.3%), and leukopenia (8.8%) were the most common clini-
cal and laboratory symptoms and acinetobacter baumannii (31.58%) and klebsiella pneumoniae (29.82%) were
the most common germs growing in sputum cultures. 19 (33.3%) cases of pan drug resistance (PDR) and 10
(17.5%) cases of extensive drug resistance (XDR) were seen. Mortality due to VAP was 78.9% and there was no
significant correlation between age (p = 0.841), sex (p = 0.473), ICU admission (p = 0.777), duration of hospital-
ization (p = 0.254), leukocytosis (p = 0.790), leukopenia (p = 0.952), fever (p = 0.171), hypothermia (p = 0.639),
type of culture (p = 0.282), and type of antibiotic resistance (p = 0.066) with mortality. Conclusion: Prevalence
of VAP and its associated mortality were 11% and 78.9%, respectively. The most common symptoms and signs
were purulent discharge, leukocytosis, and fever. Acinetobacter baumannii and klebsiella pneumoniae were the
most common germs in sputum cultures with 50% resistance to commonly used antibiotics.
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1. Introduction
T
he respiratory infection caused by micro-aspiration
of organisms, 48 hours after going under mechanical
ventilation is called ventilator-associated pneumonia
(VAP) (1). Pneumonia is one of the most common hospital
infections and a side effect of long stay in the intensive care
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unit (ICU) (2). This problem has a prevalence of 16 to 78%,
while infections of urinary tract or skin have a prevalence of
1 - 4% (2-6). Due to the important role of antibiotic-resistant
bacteria in these kinds of infection, with longer duration of
hospital stay, the probability of mortality will rise (3, 7, 8).
VAPis the reason for increased length of stay in ICU and is
responsible for about 50% of antibiotic prescriptions in this
unit. The risk of this infection has been reported to be 3%
for each day of intubation during the first 5 days, 2% for each
day during 5thto 10th day, and 1% after 10 days of intubation
(9). Among the most common germs responsible for VAP are
staphylococcus aureus, pseudomonas aeruginosa, klebsiella
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pneumoniae, and acinetobacter (4, 10). In a study on 107
patients under mechanical ventilation, prevalence of VAP
was calculated to be 28.54%, with pseudomonas aeruginosa,
meticillin resistant staphylococcus aureus, klebsiella pneu-
moniae, and acinetobacter baumannii (6). In another study,
the total rate of hospital pneumonia was found to be 26.2%
and its mortality rate was estimated to be 78.8% (11). A study
in Shiraz, Iran, also reported a 10.2% VAP rate and acineto-
bacter baumannii as the most common responsible organ-
ism (12). 2 other studies reported prevalence of VAP to be
21.6% and 16% in 2013 and 2014, respectively (13, 14). Con-
sidering the changes in pattern of common pathogens in in-
fectious diseases and raise in hospital infection rates shown
in various studies, identifying the pathogens responsible for
infections can be of great help in selecting the proper treat-
ment for VAP and is therefore a requirement and research
priority all over the world. The importance of this issue is
emphasized when we note that most of these patients have
been intubated in emergency department and stayed there
for a while. Therefore, the present study aimed to determine
the rate of VAP and its bacterial causes.
2. Methods
2.1. Study design and setting
The present study is a retrospective cross-sectional one car-
ried out on patients under mechanical ventilation in ICU or
other departments of Shohadaye Tajrish Hospital, Tehran,
Iran, during 2014-2016, aiming to determine the prevalence
of VAP and its bacterial causes in these patients. Protocol of
this study was approved by the ethics committee of Shahid
Beheshti University of Medical Sciences. The researchers ad-
hered to confidentiality of patient data and Declaration of
Helsinki principles.
2.2. Participants
All the patients that had no signs of pneumonia at the time
of intubation who developed new infiltration in chest radio-
graphy after 48 hours of intubation along with at least 2 of
the symptoms including fever, hypothermia, leukocytosis,
leukopenia, or purulent discharge from the lungs were con-
sidered VAP cases and included in the study. If the patients
had pneumonia before going under ventilation or during the
initial 48 hours or their clinical data were not available, they
were excluded. No age or sex limitation was applied and the
reason for intubation was not considered in exclusion crite-
ria. Consecutive sampling was used.
2.3. Data gathering
Demographic data of the patients (age, sex, admission ward),
results of blood cell count, smear and culture of respiratory
secretions, type of microorganism that grow, antibiotic resis-
Table 1: Demographic and clinical data of studied patients
Variable Number (%)
Age (year)
15 - 29.9 6 (11.32)
30 - 44.9 4 (7.55)
45 - 59.9 12 (22.64)






Intensive care unit 21 (36.64)

















Pan drug resistance (PDR) 19 (65.52)




tance, clinical symptoms, chest radiography findings, com-
puted tomography (CT) scan of lungs, if present, and final
outcome of the patients were extracted from their medical
profile and recorded in a checklist designed for this purpose.
Data were gathered by a senior resident of internal medicine
and when in doubt, an infectious disease specialist or an in-
ternal medicine specialist was consulted. The findings of pa-
tients’ radiography were reported by the center’s radiologist
or the pulmonologist in charge of patient management in
ICU.
2.4. Statistical Analysis
Required sample size for this study was calculated to be 456
cases considering the 5% probability of VAP (3% for each day
in the initial 5 days and 2% for each day 5-10 days after in-
tubation), α = 5% and desired precision of 2% (15). Finally,
data were analyzed using SPSS version 20 and Chi square and
t-test. Qualitative data were reported as percentage and fre-
quency, and quantitative ones as mean ± standard deviation
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(SD). To evaluate the correlation between studied variables
and final outcome (mortality) chi-square test was used. P <
0.05 was considered as significance level.
3. Results
3.1. Baseline characteristics
518 patients with the mean age of 62.3 ± 20.8 (range: 15 - 97)
years underwent mechanical ventilation via orotracheal in-
tubation during the study period (50.9% female). 57 (11%)
of cases developed VAP. Demographic data, clinical symp-
toms, and laboratory findings of the studied patients are
summarized in table 1. The highest frequency of patients
belonged to ≥ 75 years age group (30.19%). Mean time in-
terval between intubation and showing symptoms was 10.89
± 12.27 days (range: 2 – 80). Only 21 (36.8%) patients
were hospitalized in ICU and others were admitted to other
departments. Purulent discharges with 100%, leukocytosis
with 71.9%, fever with 49.1%, hypothermia with 12.3%, and
leukopenia with 8.8% were the most common clinical and
laboratory findings in the studied patients.
3.2. Cultures
Tables 2 and 3 depict the most common germ growths in
sputum culture and the results of antibiogram done for pa-
tients with VAP. The most common germ growths belonged to
acinetobacter baumannii with 31.58%, and klebsiella pneu-
moniae with 29.82%, respectively. Rate of resistance to
ciprofloxacin, doxycycline, cotrimoxazole, ceftazidime, and
cefotaxime were reported to be more than 50%. Finally, 19
(33.3%) cases of pan drug resistance (PDR) and 10 (17.5%)
cases of extensive drug resistance (XDR) were reported. No
significant correlation was detected between the type of
germ growth in sputum culture and presence of PDR or XDR
(p = 0.931). Radiography of 100% of the patients included tur-
bidity in 1 or multiple lobes.
3.3. Outcome
Mortality due to VAP in the present study was estimated to
be 78.9% (45 cases). No significant correlation was seen be-
tween age (p = 0.841), sex (p = 0.473), ICU admission (p =
0.777), duration of hospitalization (p = 0.254), leukocytosis (p
= 0.790), leukopenia (p = 0.952), fever (p = 0.171), hypother-
mia (p = 0.639), type of culture (p = 0.282), and type of antibi-
otic resistance (p = 0.066) with mortality.
4. Discussion
Based on our findings, prevalence of VAP was 11% among the
studied patients and mortality due to it was estimated to be
78.9%. The most common clinical and laboratory symptoms
and signs of this type of pneumonia were purulent discharge,
Table 2: Frequency of germs’ growth in studied patients’ sputum
culture
Growing germ Number (%)
Acinetobacter Baumannii 18 (31.6)
Klebsiella Pneumoniae 17 (29.8)
Enterobacteriaceae 7 (12.3)
Candida Albicans 4 (7)
Pseudomonas Aeruginosa 4 (7)
Staphylococcus Aureus 3 (5.3)
Escherichia Coli 2 (3.5)
Proteus Mirabilis 1 (1.8)
Negative 1 (1.8)
Table 3: Frequency of antibiotic resistance in studied patients






















leukocytosis, and fever. Acinetobacter baumannii and kleb-
siella pneumonia were the most common germs growing in
sputum cultures that showed resistance to commonly used
antibiotics in more than 50% of cases. In a study by Nadi et
al. mean age of the population affected with pneumonia in
353 patients who were hospitalized in ICU of Be’sat and Ek-
batan Hospitals, Hamedan, Iran, was 51.2 ± 21.9 years, only
36 (10.2%) of which were affected with VAP (16). As men-
tioned before, health care providers should face a big chal-
lenge named hospital infections. In the United States, every
year, an average of about 2 million people are affected with
this kind of infection and 90000 die, which makes hospital in-
fections the 5th most common cause of death in health cen-
ters (15). The most common hospital infections are reported
to be respiratory (65%), urinary tract (17%), and blood (12%)
infections (15). Ventilator associated infections have the
highest rate of mortality among hospital acquired infections,
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90% of which occur during mechanical ventilation and 50%
in the initial 4 days of going under mechanical ventilation
(15). In 2009, it was estimated that VAP increases days in need
of ventilator by 9.6 days, length of stay in ICU by 6.1 days, and
hospitalization duration by 11.5 days, which inflicts physi-
cal and financial burdens on the patient and health care sys-
tem (17). Despite measures taken and recent advances in
treatment, prevention, and management of pathogens as-
sociated with ventilator, pneumonia is still a major cause
of death in hospitalized patients. Since multi-drug resistant
pathogens play a major role in VAP, currently antibiotics that
properly cover these pathogens are used. These antibiotics
include 3rd or 4th generation of cephalosporin (ceftazidime,
cefepime), Îš-lactamase inhibitors (piperacillin, tazobac-
tam), carbapenems (imipenem, meropenem) in combi-
nation with an aminoglycoside (gentamicin, tobramycin,
amikacin) or an anti-peseudomonas fluoroquinolone (lev-
ofloxacin, ciprofloxacine) (15). In the present study, VAP had
a prevalence of 11% among patients under mechanical ven-
tilation. This rate was reported to be 19% in ICU of Shahid
Beheshti Hospital, Kashan, Iran, during 2009-2010. In that
study, a significant correlation was found between age, Glas-
gow coma scale, positioning patient’s head in 30 or more de-
grees, oral hygiene, and training the staff regarding infec-
tion control with hospital pneumonia; and continuous train-
ing of staff and taking complete and regular care of oral hy-
giene of patients under mechanical ventilation were recom-
mended (18). In a study by Chung et al., 77.3% of intubated
patients admitted to ICU had VAP (19). In a similar study,
Klompas et al. reported the prevalence of VAP to be 9.5%
among 599 patients who were hospitalized in ICU of a hos-
pital in America (20). This difference in prevalence may be
due to the method of care given, the skill and experience
of nurses, adhering to standards and beds being physically
standard, positioning of patient’s head, space between beds
and their rate of occupation, use of gloves and gowns by staff,
oral hygiene, prevention of stomach distension, and method
of prophylactic antibiotic use. Therefore, the higher the rate
of standard treatments carried out for intubated patients, the
lower the rate of pneumonia. In the present study, there was
no significant difference between ICU of departments (in-
ternal medicine and surgery) regarding incidence of pneu-
monia or final outcome of mortality. In a study in Arak car-
ried out in 2011, there was a significant difference between
ICU of internal medicine and surgery wards (21). In addi-
tion, in the Klompas et al. study, prevalence of pneumonia
was 33% in internal medicine ward and 61% in surgery wad.
This difference might be due to more invasive procedures,
catheterization, intubation duration, and higher length of
stay in surgery ward compared to internal medicine ward
(20). The most common pathogens extracted from patients
in the present study were acinetobacter baumannii and kleb-
siella pneumoniae, while in another study the most common
pathogens were acinetobacter, staphylococcus aureus, and
pseudomonas aeruginosa (21). In 2 separate studies, com-
mon germs responsible for pneumonia were staphylococcus
aureus, pseudomonas aeruginosa, klebsiella pneumoniae,
andacinetobacter, which is somehow similar to the present
study (4, 10). In addition, in pediatric ICU, the most common
germs in sputum of pneumonia patients were staphylococ-
cus aureus, pseudomonas aeruginosa, and enterobacter (22).
Regarding resistance to antibiotics in this study, pathogens
were resistant to ciprofloxacin, doxycycline, cotrimoxazole,
ceftazidime, and cefotaxime more than 50%. In a similar
study, acinetobacter had the most resistance to gentamicin
and was most sensitive to imipenem (21). Sadly, 78.9% of
our studied patients died because of VAP. In a study by Zarin-
far, 11.7% of the patient fully recovered, 18.3% were relatively
better, 20% did not get better, and 50% died, which is lower
than the rate in our study. As mentioned before, this might be
due to the procedures done, method of intubation, physical
health, positioning of patient’s head, and type of antibiotic
prescribed (21).
5. Limitation
Among the limitations of this study were its retrospective de-
sign and extracting data from patients’ medical profile, which
increase the probability of losing some information due to
careless profile recording. In addition, data regarding the un-
derlying disease and cause of intubation were not consid-
ered, while they may play a role in increasing mortality due
to ventilation.
6. Conclusion
Based on our findings, prevalence of VAP and its associated
mortality were 11% and 78.9%, respectively. The most com-
mon symptoms and signs were purulent discharge, leuko-
cytosis, and fever. Acinetobacter baumannii and klebsiella
pneumoniae were the most common germs in sputum cul-
tures with 50% resistance to commonly used antibiotics.
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